Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation

Carcinogenesis

Volumn 22, Issue 8, 2001, Pages 1163-1172

  Messner, D J ^a   Jagdale, P Ao A B ^a   Boynton, A L ^a  

^a NORTHWEST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; EPIDERMAL GROWTH FACTOR; METHYLNITRONITROSOGUANIDINE; OKADAIC ACID; PROTEIN P130; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; SERINE; THYMIDINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; EPITHELIUM CELL; INHIBITION KINETICS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TUMOR PROMOTION;

EID: 0034902975     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.8.1163     Document Type: Article

References (71)

1. Isolation and structural elucidation of the causative toxin of diarrhetic shellfish poisoning
2. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases
3. Okadaic acid: A new probe for the study of cellular regulation
4. Serine/threonine protein phosphatases and their inhibitors
5. Protein serine/threonine phosphatases - New avenues for cell regulation
6. Protein serine/threonine phosphatases and cell transformation
7. Regulation of gene expression by serine/threonine protein phosphatases
8. Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter
9. Specific mechanistic aspects of animal tumor promoters: The okadaic acid pathway
10. 1 events and regulation of cell proliferation
11. Cancer cell cycles
12. Principles of CDK regulation
13. Role of the Rb/E2F pathway in cell growth control
14. 1-phase progression
15. kip-1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
16. The p53 network
17. The complexity of p53 modulation: Emerging patterns from divergent signals
18. The INK4A/ARF locus and its two gene products
19. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatase, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells
20. 2-phase to induce premature mitosis in HeLa cells
21. Transcriptional and post-transcriptional regulation of c-fos expression by the tumor promoter okadaic acid
22. 1 arrest in quiescent and senescent cells treated with phosphatase inhibitors
23. Mitotic arrest and enhanced nuclear protein phosphorylation in human leukemia K562 cells by okadaic acid, a potent protein phosphatase inhibitor and tumor promoter
24. Selective induction of cell cycle regulatory genes cdk1 (p34cdc2), cyclins A/B and the tumor suppressor gene Rb in transformed cells by okadaic acid
25. Apoptosis and mitotic arrest are two independent effects of the protein phosphatases inhibitor okadaic acid in K562 leukemia cells
26. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation and cell proliferation by the phosphatase inhibitor okadaic acid
27. Okadaic acid inhibits PDGF-induced proliferation and decreases PDGF receptor number in C3H/10T1/2 mouse fibroblasts
28. Okadaic acid regulation of the retinoblastoma gene product is correlated with the inhibition of growth factor-induced cell proliferation in mouse fibroblasts
29. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A
30. Cell cycle-independent regulation of p21 (cip-1) and retinoblastoma protein during okadaic-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells
31. Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation
32. Okadaic acid and phorbol esters: Comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro
33. Okadaic acid: A reversible inhibitor of neoplastic transformation of mouse fibroblasts
34. Role of protein phosphatases in malignant transformation
35. Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter
36. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding
37. Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53
38. Regulation of p21 (waf1/cip1) expression by p53-independent pathways
39. Regulation of protein kinase cascades by protein phosphatase 2A
40. Regulation of proliferation of normal and neoplastic rat liver cells by calcium and cyclic AMP
41. Relation between colony formation in calcium deficient medium, colony formation in soft agar and tumor formation by rat T51B cells
42. The different actions of normal and supranormal calcium concentration on the proliferation of Balb/c 3T3 mouse cells
43. The mannose receptor and the cation-dependent form of mannose 6-phosphate receptor have overlapping cellular and subcellular distributions in liver
44. Calcium-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts
45. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells
46. Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A
47. Distinct roles for E2F proteins in cell growth control and apoptosis
48. The retinoblastoma gene family in differentiation and development
49. 1 state
50. Role of the retinoblastoma protein family, pRb, p107 and p130 in the negative control of cell growth
51. Purification of protein phosphatase 4 catalytic subunit: Inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters
52. A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus
53. Purification of a fatty acid-stimulated protein serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5
54. Molecular cloning, expression and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC)
55. Differential activities of E2F family members: Unique functions in regulating transcription
56. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
57. Functional analysis of pRb2/p130 interaction with cyclins
58. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27kip1-deficient cells
59. 0 lead to its association with E2F4
60. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells
61. Control and activity of type-1 serine/threonine protein phosphatase during the cell cycle
62. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein
63. Mechanisms of switching on p53: A role for covalent modification?
64. Signaling to p53: Breaking the MDM2 circuit
65. Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15
66. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by casein 1-like kinase
67. Novel phosphorylation sites of human tumor suppressor protein p53 at ser 20 and thr 18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers
68. The human homologs of checkpoint kinases chk1 and cds1 (chk2) phosphorylate p53 at multiple DNA damage-inducible sites
69. Sensitization to DNA damage by okadaic acid or bromodeoxyuridine involves unequal effects on melanoma cell adhesion and differentiation
70. Maintenance of genomic integrity by p53: Complementary roles for activated and non-activated p53
71. E1A signaling to p53 involves the p19 (ARF) tumor supressor